Vitalhub Corp. (TSE:VHI – Free Report) – Equities researchers at Raymond James cut their Q3 2025 earnings per share estimates for Vitalhub in a research note issued to investors on Sunday, May 11th. Raymond James analyst M. Freeman now anticipates that the company will post earnings per share of $0.05 for the quarter, down from their previous estimate of $0.06. Raymond James currently has a “Moderate Buy” rating on the stock. The consensus estimate for Vitalhub’s current full-year earnings is $0.23 per share. Raymond James also issued estimates for Vitalhub’s Q3 2026 earnings at $0.07 EPS and FY2027 earnings at $0.35 EPS.
A number of other analysts have also recently commented on VHI. Canaccord Genuity Group boosted their price objective on Vitalhub from C$12.00 to C$12.50 and gave the company a “buy” rating in a research report on Thursday, January 16th. Scotiabank set a C$14.00 price target on Vitalhub and gave the stock an “outperform” rating in a research note on Thursday, January 30th. Finally, TD Securities boosted their price objective on Vitalhub from C$13.00 to C$14.00 and gave the stock a “buy” rating in a research note on Monday, March 31st. Four research analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of C$12.90.
Vitalhub Price Performance
Vitalhub stock opened at C$10.68 on Tuesday. Vitalhub has a 52 week low of C$6.50 and a 52 week high of C$12.34. The company has a market capitalization of C$577.71 million, a price-to-earnings ratio of 173.71, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. The stock has a 50-day moving average price of C$9.96 and a 200 day moving average price of C$10.64.
Vitalhub Company Profile
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
See Also
- Five stocks we like better than Vitalhub
- What Do S&P 500 Stocks Tell Investors About the Market?
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
- Using the MarketBeat Dividend Tax Calculator
- Why Boeing May Be Ready to Take Off After Latest Developments
- Why Invest in High-Yield Dividend Stocks?
- eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.